Código QR

Brexit – The Consequences for Pharmaceutical Patents and Supplementary Protection Certificates

Now that the UK has left the EU, and the transition period following this departure is over, we have a clearer view on the implications of Brexit on intellectual property rights and the consequences for UK based pharmaceutical companies. Although little has changed for UK applicants wishing to obta...

Descrición completa

Gardado en:
Detalles Bibliográficos
Principais autores: Harry Melville O'Brien, Anna Louise Hatt, James Alexander Stones
Formato: Artigo
Idioma:Inglês
Publicado: University of Huddersfield Press 2021-05-01
Series:British Journal of Pharmacy
Assuntos:
Acceso en liña:https://www.bjpharm.org.uk/article/id/896/
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!